IMS Health Holdings, the health care information and technology provider, and Quintiles Transnational Holdings, which assists pharmaceutical companies with clinical trial research, said on Tuesday that they had agreed to an all-stock “merger of equals.”
The merger would create a combined company worth $17.6 billion based on market capitalization and with $7.2 billion in pro forma revenue in 2015. (Ver)
Ver también:
Entradas
No hay comentarios:
Publicar un comentario